Article Text


CTLA4 polymorphisms in primary biliary cirrhosis patients and first degree relatives of cretan origin
  1. A Mantaka1,
  2. M Koulentaki2,
  3. O Tsagournis2,
  4. V Galanakis1,
  5. E Kouroumalis *1,2
  1. 1Liver Research Laboratory, University of Crete, Heraklion, Greece
  2. 2Gastroenterology, University Hospital, Heraklion, Greece


Introduction and background Cytotoxic T lymphocyte antigen 4 (CTLA4) encodes a coinhibitory immunoreceptor that is a key regulator of self tolerance with established genetic associations to multiple autoimmune diseases. Studies of CTLA4 in PBC identified an association with the G allele of 49AG in Chinese and French patients, but not in the USA, Brazil, UK, Italy and Germany ones.

Aims To examine whether CTLA-4 CT60 and/or +49A/G polymorphisms are involved in the genetic predisposition to PBC in a genetically homogeneous Cretan population.

Methods The authors studied 91 PBC patients (77 female, 9 AMA-), median age 68 years (41–84 years), Ludwig stage III–IV: 43/91, 101 first degree relatives (FDR, 63 females), median age 40 years (18–80 years), 3/101 AMA+ and 100 healthy controls (76 female), median age 69 years (39–86 years), 16/100 ANA+, all of Cretan origin. After the isolation of genomic DNA from peripheral blood mononuclear cells, CTLA-4 CT60 and +49A/G polymorphisms were genotyped by restriction fragment length polymorphism with the use of BbvI (+49A/G) and NlaIII (CT60). Distribution of genotypes and alleles were compared by x2 test.

Results The genotypes AA, AG and GG of the polymorphism rs231775 of CTLA4 gene were 41 (45.1%), 47 (51.6%) and 3 (3.3%) in the PBC patients, 58 (57.4%), 39 (38.6%) and 4 (4%) in the FDR and 46 (46%), 47 (47%) and 7 (7%) in the control group. No statistical differences were found among groups (PBC vs controls p=0.48, FDR vs controls p=0.23) and no association of the genotypes with disease stage (p=0.178).

The genotypes AA, AG and GG of the genetic polymorphism rs3087243 of CTLA4 gene were 22 (24.1%), 39 (42.9%) and 30 (33%) in the PBC patients, 25 (24.8%), 59 (58.4%) and 17 (16.8%) in the FDR and 24 (24%), 52 (52%) and 24 (24%) in the control group. No statistical differences of the genotypes were found among groups (PBC vs controls p=0.334, FDR vs controls p=0.438) and no association with disease stage (p=0.316).

Conclusions rs3087243 and rs231775 CTLA4 gene polymorphisms have no association with either susceptibility to PBC or disease stage in a genetically homogeneous population of Cretan origin.

  • CTLA4
  • primary biliary cirrhosis.

Statistics from


  • Competing interests None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.